C

China Medical System Holdings Ltd
HKEX:867

Watchlist Manager
China Medical System Holdings Ltd
HKEX:867
Watchlist
Price: 13.96 HKD 2.35% Market Closed
Market Cap: 34.1B HKD

Gross Margin
China Medical System Holdings Ltd

71.5%
Current
75%
Average
48.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.5%
=
Gross Profit
5.6B
/
Revenue
7.9B

Gross Margin Across Competitors

No Stocks Found

China Medical System Holdings Ltd
Glance View

Market Cap
34.1B HKD
Industry
Pharmaceuticals

China Medical System Holdings Ltd., a notable player in the Chinese pharmaceutical landscape, has woven a strategy that cleverly integrates proprietary drug development with a robust marketing apparatus. Established in 1995 and headquartered in Shenzhen, the company has developed a knack for identifying pharmaceuticals and medical devices with promising potential. Their business model hinges on acquiring exclusive rights to a carefully curated portfolio of international products, which they then introduce to the burgeoning Chinese market. By leveraging their deep understanding of market dynamics and regulatory environments, they effectively roll out these products, ensuring that they meet local demand and adhere to high compliance standards. The company's revenue engine is powered predominantly by its dynamic sales and marketing network which spans across mainland China. They employ a multifaceted distribution model, partnering with an extensive range of hospitals and healthcare providers to facilitate widespread adoption of their products. But what truly sets China Medical System Holdings apart is its focus on products that are already well advanced within their lifecycle, minimizing the usual risks associated with early-stage pharmaceutical development. This strategic approach not only ensures steady cash flows but also reduces overhead costs associated with R&D, allowing them to reinvest profits into acquiring new products and expanding their market footprint. As such, their business thrives on a cycle of discernment and targeted expansion, positioning them as a formidable entity in the healthcare sector.

Intrinsic Value
13.34 HKD
Overvaluation 4%
Intrinsic Value
Price
C
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
71.5%
=
Gross Profit
5.6B
/
Revenue
7.9B
What is the Gross Margin of China Medical System Holdings Ltd?

Based on China Medical System Holdings Ltd's most recent financial statements, the company has Gross Margin of 71.5%.

Back to Top